SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines

The company's proprietary platform combines an ultrasound-mediated delivery technology with payload engineering capabilities that support the development of DNA and RNA therapeutics, gene editing, and gene silencing approaches.

The post SonoThera Raises $125M to Develop Ultrasound-Mediated Genetic Medicines appeared first on GEN - Genetic Engineering and Biotechnology News.